A clinical study of HBsAg-activated dendritic cells and cytokine-induced killer cells during the treatment for chronic hepatitis B

Scandinavian Journal of Immunology

Volumn 78, Issue 4, 2013, Pages 387-393

  Ma, Y J ^a   He, M ^b   Han, J A ^a   Yang, L ^a   Ji, X Y ^c  

^a ZHENGZHOU PEOPLE S HOSPITAL   (China)

^b Henan Provincial Vocational College for Nursing   (China)

^c HENAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; B7 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 12; T6 ANTIGEN; VIRUS DNA;

ADOPTIVE IMMUNOTHERAPY; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; AUTOTRANSPLANTATION; CELL ACTIVATION; CELL CULTURE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; DENDRITIC CELL; FEMALE; FEVER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT RESPONSE; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS LOAD;

ADOLESCENT; ADOPTIVE TRANSFER; ADULT; CELLS, CULTURED; CYTOKINE-INDUCED KILLER CELLS; DENDRITIC CELLS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION; YOUNG ADULT;

EID: 84883803903     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12097     Document Type: Article

References (18)

1. Michel ML, Deng Q, Mancini-Bourgine M. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J Hepatol 2011;54:1286-96.
2. Chisari FV, Ferrari C. Hepatitis B virus immunopathology. Springer Semin Immunopathol 1995;17:261-81.
3. Ferrari C, Penna A, Bertoletti A et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990;145:3442-9.
4. Chen M, Li YG, Zhang DZ et al. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study. World J Gastroenterol 2005;11:1806-8.
5. Luo J, Li J, Chen RL et al. Autologus dendritic cell vaccine for chronic hepatitis B carriers: a pilot, open label, clinical trial in human volunteers. Vaccine 2010;28:2497-504.
6. Hepatology of Chinese Medical Association, Chinese Medical Association to infectious diseases. Chronic hepatitis B prevention and treatment guidelines. Liver 2011;16:2-16.
7. Chen JM, Wei XM, Chen ZZ. Ex vivo culture of dendritic From peripheral blood cells. Cell Res 2001;23:40-2.
8. Xuanyong Lu. Pathogenesis of Hepatitis B Virus (HBV)-Mediated Liver Injury. N A J Med Sci 2011;4:1-6.
9. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010;58:258-66.
10. Min XG. Study of changes in immune response in patients with chronic hepatitis B. J Hosp Infect 2012;22:280-2.
11. Zhang Z, Zhang JY, Wang LF. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol 2012;27:223-30.
12. Shimizu Y. Immunopathogenesis and immunotherapy for viral hepatitis. In: Mukololov S, ed. Viral Hepatitis-Selected Issues of Pathogenesis and Diagnosis, Shanghai, China: InTech China, 2011:65-82.
13. Horiike N, Md Fazle Akbar S, Ninomiya T, Abe M, Michitaka K, Onji M. Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus. Hepatol Res 2002;23:38-47.
14. Su HB, Li HW, Zhao HL et al. Therapeutic effect of autologous cytokine-induced killer cells on patients with liver cirrhosis caused by HBV infection. Chin J Exp Clin Virol 2007;21:64-6.
15. Märten A, Ziske C, Schöttker B et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J Immunother 2001;24:502-10.
16. van der Molen RG, Sprengers D, Binda RS et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004;40:738-46.
17. Ma Y-J, Han J-A, Yang L, Wang Z-L, Han L, Wang Y-J. Immune effector differences of dendritic cells after HBsAg activation in healthy subjects and Chronic HBV infected patients. World J Gastroenterol 2012;20:341-5.
18. Shi M, Fu J, Shi F et al. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clin Immunol 2009;132:43-54.